Patients' experiences of long-acting injectable antipsychotics: a qualitative study

被引:5
|
作者
Chiu, Lin-Ling [1 ]
Liu, Chun-Hao [2 ,3 ]
Chu, Chun-Lin [4 ]
Lin, Huang-Li [2 ]
Lii, Shu-Chung [5 ]
机构
[1] Chang Gung Univ, Coll Med, Sch Med, Taoyuan, Taiwan
[2] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp Linkou, Dept Child Psychiat, Taoyuan, Taiwan
[4] Chang Gung Mem Hosp Taoyuan, Dept Psychiat, Taoyuan, Taiwan
[5] Chang Gung Univ, Coll Med, Humanist & Social Med Div, 259 Wen Hua 1st Rd, Taoyuan 333, Taiwan
关键词
antipsychotics; experience; long-acting injectable; LAI; qualitative research; SCHIZOPHRENIA; INJECTIONS; PROGRAM;
D O I
10.2147/NDT.S206154
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: In this study, we applied a qualitative approach to explore patients' subjective experiences of long-acting injectable antipsychotics (LAIs). Methods: Patients undergoing psychiatric treatment from the chronic ward or outpatient department of a medical center in northern Taiwan who had experience with LAI treatment were enrolled. Information was obtained through semi-structured in-depth interviews. The interviews were audio-recorded and then translated verbatim, and the data were collected and analyzed concurrently to develop major themes and categories. Result: In total, 14 participants (8 female) were interviewed. In a bio-psycho-social model, the participants used LAIs as a method to become "normal," in order to achieve a balance between the "effects" and "side effects" that may influence their daily lives. Their past experiences constructed their concepts about and expectations regarding LAIs, and their relationships with their family members and co-workers also modeled their experiences. Conclusion: In our study, we sought to understand the experience of LAI in the daily life context of the patients. We attempted to use a bio-psycho-social model to evaluate the subjective experience of the patients; an improved understanding can help mental health specialists gain a closer insight into patient experience.
引用
收藏
页码:1797 / 1804
页数:8
相关论文
共 50 条
  • [31] Long-acting injectable atypical antipsychotics in adolescent population: an observational study
    Fortea, A.
    Espinosa, L.
    Ilzarbe, D.
    Solerdelcoll, M.
    De Castro, C.
    Oriolo, G.
    Sugranyes, G.
    Baeza, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S732 - S733
  • [32] Industry effects on evidence: a case study of long-acting injectable antipsychotics
    Cosgrove, Lisa
    Mintzes, Barbara
    Bursztajn, Harold J.
    D'Ambrozio, Gianna
    Shaughnessy, Allen F.
    ACCOUNTABILITY IN RESEARCH-ETHICS INTEGRITY AND POLICY, 2024, 31 (01): : 2 - 13
  • [33] Long-Acting Injectable Antipsychotics in the ElderlyGuidelines for Effective Use
    Prakash S. Masand
    Sanjay Gupta
    Drugs & Aging, 2003, 20 : 1099 - 1110
  • [34] Effectiveness of long-acting injectable antipsychotics: a clinical perspective
    Castillo, Enrico G.
    Stroup, T. Scott
    EVIDENCE-BASED MENTAL HEALTH, 2015, 18 (02) : 36 - 39
  • [36] Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain
    Arango, Celso
    Baeza, Inmaculada
    Bernardo, Miquel
    Canas, Fernando
    de Dios, Consuelo
    Diaz-Marsa, Marina
    Paz Garcia-Portilla, Maria
    Gutierrez-Rojas, Luis
    Manuel Olivares, Jose
    Rico-Villademoros, Fernando
    Rodriguez-Jimenez, Roberto
    Maria Sanchez-Morla, Eva
    Segarra, Rafael
    Crespo-Facorro, Benedicto
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2019, 12 (02): : 92 - 105
  • [37] Long-acting injectable antipsychotics: choosing the right dose
    Carlone, David
    Delva, Nicholas
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2020, 45 (04): : 298 - 298
  • [38] Interpreting evidence on long-acting injectable antipsychotics Comment
    Morrato, Elaine H.
    LANCET PSYCHIATRY, 2021, 8 (05): : 349 - 351
  • [39] Population pharmacokinetics and dosing of long-acting injectable antipsychotics
    Kim, David D.
    Barr, Alasdair M.
    Rafizadeh, Reza
    Procyshyn, Ric M.
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2021, 46 (05): : E516 - E517
  • [40] Long-Acting Injectable Antipsychotics: An Underutilized Treatment Option
    Heres, Stephan
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (11) : 1263 - 1265